Fortis Medical Devices is a company headquartered in Ireland.
Fortis Medical Devices develops cueStim, a non-invasive medical device intended to reduce the frequency and severity of Freezing of Gait (FoG) episodes in people with Parkinson's disease. The company's device is being developed as a Class II De Novo medical device and has been designated an FDA Breakthrough Technology and included in the FDA TAP pilot program.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.